Glaxosmithkline Pharmaceuticals Ltd. | GLAXO | NSE - Pharmaceuticals
INR in Million. Fiscal year ends in March. Figures are consolidated and restated..
Upgrade Membership to see 10 year accurate financial statements.
Chart | 2017 | 2018 | 2019 | 2020 | 2021 | |
---|---|---|---|---|---|---|
Net Income |
| 4,655 | 5,222 | 6,540 | 6,472 | 7,231 |
Cash flow Operating Act... |
| 2,360 | 4,728 | 3,994 | 4,905 | 5,779 |
Investments in PPE |
| -3,044 | -4,034 | -2,913 | -1,559 | -442 |
Cash flow Investing Act... |
| 3,008 | -1,042 | -1,433 | -568 | 4,186 |
Dividend Paid |
| 4,235 | 2,541 | 2,965 | 4,085 | 6,776 |
Cash flow Financing Act... |
| -5,108 | -3,066 | -3,584 | -4,276 | -6,961 |
Cash at beginning of period |
| 1,149 | 1,391 | 2,011 | 988 | 1,048 |
Cash at end of period |
| 1,409 | 2,011 | 988 | 1,048 | 4,052 |
Free Cash Flow |
| -684 | 694 | 1,081 | 3,346 | 5,337 |